A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe. The aim of this clinical trial was to look into the
concentration of NN1250 (insulin degludec/insulin 454) in the blood after one injection of
NN1250 in children, adolescents and adults with type 1 diabetes.